• Biopharma execs seek to avoid pain points in AI integration

  • Apr 16 2024
  • Duración: 19 m
  • Podcast

Biopharma execs seek to avoid pain points in AI integration Por arte de portada

Biopharma execs seek to avoid pain points in AI integration

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Because artificial intelligence is such a new technology it comes with a mountain of unknowns. Integrating it into a pharmaceutical company presents a unique series of challenges, as a new survey from Verix shows. The report is based on responses from directors, vice presidents and C-suite executives in sales, marketing and brand management at pharmaceutical companies in the U.S. that have more than $100 million in annual revenue. Doron Aspitz, the CEO of Verix, talked about the new findings with the BioWorld Insider podcast and the profound shift that executives face as the new technology takes over an entire industry.

    Más Menos
activate_primeday_promo_in_buybox_DT
Más Menos

Lo que los oyentes dicen sobre Biopharma execs seek to avoid pain points in AI integration

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles